Catalyst
Slingshot members are tracking this event:
AxoGen (AXGN) Phase 3 Study Comparing Nerve Cuffs and Nerve Graft treatment in curing Peripheral Nerve Discontinuities set for August 2021 primary completion date
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AXGN |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 01, 2021
Occurred Source:
https://ir.axogeninc.com/press-releases/detail/921/axogen-reconsm-clinical-study-completes-subject-follow-up
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Peripheral Nerve Discontinuities, Phase 3 Study
